174 related articles for article (PubMed ID: 19801670)
1. Phosphoglucose isomerase/autocrine motility factor promotes melanoma cell migration through ERK activation dependent on autocrine production of interleukin-8.
Araki K; Shimura T; Yajima T; Tsutsumi S; Suzuki H; Okada K; Kobayashi T; Raz A; Kuwano H
J Biol Chem; 2009 Nov; 284(47):32305-11. PubMed ID: 19801670
[TBL] [Abstract][Full Text] [Related]
2. AMF/PGI-mediated tumorigenesis through MAPK-ERK signaling in endometrial carcinoma.
Li Y; Jia Y; Che Q; Zhou Q; Wang K; Wan XP
Oncotarget; 2015 Sep; 6(28):26373-87. PubMed ID: 26308071
[TBL] [Abstract][Full Text] [Related]
3. Raft-dependent endocytosis of autocrine motility factor/phosphoglucose isomerase: a potential drug delivery route for tumor cells.
Kojic LD; Wiseman SM; Ghaidi F; Joshi B; Nedev H; Saragovi HU; Nabi IR
PLoS One; 2008; 3(10):e3597. PubMed ID: 18974847
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of phosphoglucose isomerase/autocrine motility factor enhances gensenoside Rh2 pharmacological action on leukemia KG1α cells.
You ZM; Zhao L; Xia J; Wei Q; Liu YM; Liu XY; Chen DL; Li J
Asian Pac J Cancer Prev; 2014; 15(3):1099-104. PubMed ID: 24606425
[TBL] [Abstract][Full Text] [Related]
5. Autocrine motility factor (neuroleukin, phosphohexose isomerase) induces cell movement through 12-lipoxygenase-dependent tyrosine phosphorylation and serine dephosphorylation events.
Timár J; Tóth S; Tóvári J; Paku S; Raz A
Clin Exp Metastasis; 1999; 17(10):809-16. PubMed ID: 11089878
[TBL] [Abstract][Full Text] [Related]
6. Induction of hepatoma cells migration by phosphoglucose isomerase/autocrine motility factor through the upregulation of matrix metalloproteinase-3.
Yu FL; Liao MH; Lee JW; Shih WL
Biochem Biophys Res Commun; 2004 Jan; 314(1):76-82. PubMed ID: 14715248
[TBL] [Abstract][Full Text] [Related]
7. The secreted glycolytic enzyme GPI/AMF stimulates glioblastoma cell migration and invasion in an autocrine fashion but can have anti-proliferative effects.
Kathagen-Buhmann A; Maire CL; Weller J; Schulte A; Matschke J; Holz M; Ligon KL; Glatzel M; Westphal M; Lamszus K
Neuro Oncol; 2018 Nov; 20(12):1594-1605. PubMed ID: 30053149
[TBL] [Abstract][Full Text] [Related]
8. Autocrine motility factor signaling enhances pancreatic cancer metastasis.
Tsutsumi S; Yanagawa T; Shimura T; Kuwano H; Raz A
Clin Cancer Res; 2004 Nov; 10(22):7775-84. PubMed ID: 15570012
[TBL] [Abstract][Full Text] [Related]
9. Novel roles of the autocrine motility factor/phosphoglucose isomerase in tumor malignancy.
Yanagawa T; Funasaka T; Tsutsumi S; Watanabe H; Raz A
Endocr Relat Cancer; 2004 Dec; 11(4):749-59. PubMed ID: 15613449
[TBL] [Abstract][Full Text] [Related]
10. Regulation of phosphoglucose isomerase/autocrine motility factor expression by hypoxia.
Funasaka T; Yanagawa T; Hogan V; Raz A
FASEB J; 2005 Sep; 19(11):1422-30. PubMed ID: 16126909
[TBL] [Abstract][Full Text] [Related]
11. Comparison of autocrine mechanisms promoting motility in two metastatic cell lines: human melanoma and ras-transfected NIH3T3 cells.
Seiki M; Sato H; Liotta LA; Schiffmann E
Int J Cancer; 1991 Nov; 49(5):717-20. PubMed ID: 1657797
[TBL] [Abstract][Full Text] [Related]
12. Autocrine motility factor modulates EGF-mediated invasion signaling.
Kho DH; Zhang T; Balan V; Wang Y; Ha SW; Xie Y; Raz A
Cancer Res; 2014 Apr; 74(8):2229-37. PubMed ID: 24576828
[TBL] [Abstract][Full Text] [Related]
13. Tumor autocrine motility factor responses are mediated through cell contact and focal adhesion rearrangement in the absence of new tyrosine phosphorylation in metastatic cells.
Silletti S; Paku S; Raz A
Am J Pathol; 1996 May; 148(5):1649-60. PubMed ID: 8623932
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of phosphoglucose isomerase/autocrine motility factor results in mesenchymal-to-epithelial transition of human lung fibrosarcoma cells.
Funasaka T; Hu H; Yanagawa T; Hogan V; Raz A
Cancer Res; 2007 May; 67(9):4236-43. PubMed ID: 17483335
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor binding protein-3 interacts with autocrine motility factor/phosphoglucose isomerase (AMF/PGI) and inhibits the AMF/PGI function.
Mishra S; Raz A; Murphy LJ
Cancer Res; 2004 Apr; 64(7):2516-22. PubMed ID: 15059907
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of the autocrine motility factor/phosphoglucose isomerase induces transformation and survival of NIH-3T3 fibroblasts.
Tsutsumi S; Hogan V; Nabi IR; Raz A
Cancer Res; 2003 Jan; 63(1):242-9. PubMed ID: 12517804
[TBL] [Abstract][Full Text] [Related]
17. Autocrine motility factor promotes endometrial cancer progression by targeting GPER-1.
Li Y; Jia Y; Bian Y; Tong H; Qu J; Wang K; Wan XP
Cell Commun Signal; 2019 Mar; 17(1):22. PubMed ID: 30836961
[TBL] [Abstract][Full Text] [Related]
18. Silencing of phosphoglucose isomerase/autocrine motility factor decreases U87 human glioblastoma cell migration.
Li Y; Wei Z; Dong B; Lian Z; Xu Y
Int J Mol Med; 2016 Apr; 37(4):998-1004. PubMed ID: 26936801
[TBL] [Abstract][Full Text] [Related]
19. Raft endocytosis of AMF regulates mitochondrial dynamics through Rac1 signaling and the Gp78 ubiquitin ligase.
Shankar J; Kojic LD; St-Pierre P; Wang PT; Fu M; Joshi B; Nabi IR
J Cell Sci; 2013 Aug; 126(Pt 15):3295-304. PubMed ID: 23690547
[TBL] [Abstract][Full Text] [Related]
20. Activation of small GTPase Rho is required for autocrine motility factor signaling.
Tsutsumi S; Gupta SK; Hogan V; Collard JG; Raz A
Cancer Res; 2002 Aug; 62(15):4484-90. PubMed ID: 12154059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
